Search Results Search Sort by RelevanceMost Recent AMA Code Says Aug 2016 AMA Code of Medical Ethics’ Opinions Applicable to Pathology Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics’ opinions related to pathology. AMA J Ethics. 2016;18(8):800-801. doi: 10.1001/journalofethics.2016.18.8.coet1-1608. Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310. Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613. In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619. State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
AMA Code Says Aug 2016 AMA Code of Medical Ethics’ Opinions Applicable to Pathology Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics’ opinions related to pathology. AMA J Ethics. 2016;18(8):800-801. doi: 10.1001/journalofethics.2016.18.8.coet1-1608.
Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310.
Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613.
In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619.
State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624.